Annual Shareholders Equity
$185.44 M
-$85.90 M-31.66%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual stockholders equity is $185.44 million, with the most recent change of -$85.90 million (-31.66%) on September 30, 2024.
- During the last 3 years, ARWR annual shareholders equity has fallen by -$223.38 million (-54.64%).
- ARWR annual shareholders equity is now -59.84% below its all-time high of $461.78 million, reached on September 30, 2020.
Performance
ARWR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$185.44 M
-$145.10 M-43.90%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly stockholders equity is $185.44 million, with the most recent change of -$145.10 million (-43.90%) on September 30, 2024.
- Over the past year, ARWR quarterly shareholders equity has dropped by -$298.35 million (-61.67%).
- ARWR quarterly shareholders equity is now -62.92% below its all-time high of $500.08 million, reached on December 31, 2019.
Performance
ARWR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ARWR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | -61.7% |
| 3 y3 years | -54.6% | -54.6% |
| 5 y5 years | -24.2% | -54.6% |
ARWR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -61.7% | +15.6% |
| 5 y | 5-year | -59.8% | at low | -62.9% | +15.6% |
| alltime | all time | -59.8% | +6728.4% | -62.9% | >+9999.0% |
Arrowhead Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $185.44 M(-31.7%) | $185.44 M(-43.9%) |
| Jun 2024 | - | $330.55 M(-31.7%) |
| Mar 2024 | - | $483.79 M(+201.6%) |
| Dec 2023 | - | $160.41 M(-40.9%) |
| Sep 2023 | $271.34 M(-31.9%) | $271.34 M(-25.6%) |
| Jun 2023 | - | $364.83 M(-18.3%) |
| Mar 2023 | - | $446.77 M(+18.5%) |
| Dec 2022 | - | $377.04 M(-5.4%) |
| Sep 2022 | $398.52 M(-2.5%) | $398.52 M(-12.2%) |
| Jun 2022 | - | $453.93 M(+0.4%) |
| Mar 2022 | - | $452.27 M(+21.4%) |
| Dec 2021 | - | $372.56 M(-8.9%) |
| Sep 2021 | $408.82 M(-11.5%) | $408.82 M(-6.4%) |
| Jun 2021 | - | $436.89 M(-1.9%) |
| Mar 2021 | - | $445.55 M(-2.0%) |
| Dec 2020 | - | $454.47 M(-1.6%) |
| Sep 2020 | $461.78 M(+88.8%) | $461.78 M(-6.4%) |
| Jun 2020 | - | $493.14 M(-0.2%) |
| Mar 2020 | - | $494.12 M(-1.2%) |
| Dec 2019 | - | $500.08 M(+104.5%) |
| Sep 2019 | $244.59 M(+155.3%) | $244.59 M(+8.1%) |
| Jun 2019 | - | $226.23 M(+12.4%) |
| Mar 2019 | - | $201.20 M(+16.9%) |
| Dec 2018 | - | $172.06 M(+79.6%) |
| Sep 2018 | $95.80 M(+17.7%) | $95.80 M(-6.4%) |
| Jun 2018 | - | $102.31 M(-10.5%) |
| Mar 2018 | - | $114.27 M(+61.5%) |
| Dec 2017 | - | $70.75 M(-13.1%) |
| Sep 2017 | $81.42 M(-14.8%) | $81.42 M(-9.6%) |
| Jun 2017 | - | $90.10 M(-4.0%) |
| Mar 2017 | - | $93.89 M(-4.0%) |
| Dec 2016 | - | $97.76 M(+2.3%) |
| Sep 2016 | $95.58 M(-13.2%) | $95.58 M(+59.4%) |
| Jun 2016 | - | $59.98 M(-19.5%) |
| Mar 2016 | - | $74.48 M(-19.8%) |
| Dec 2015 | - | $92.92 M(-15.7%) |
| Sep 2015 | $110.18 M(-33.8%) | $110.18 M(-16.1%) |
| Jun 2015 | - | $131.30 M(-9.3%) |
| Mar 2015 | - | $144.75 M(-1.0%) |
| Dec 2014 | - | $146.26 M(-12.2%) |
| Sep 2014 | $166.54 M(+505.6%) | $166.54 M(-10.6%) |
| Jun 2014 | - | $186.36 M(-2.6%) |
| Mar 2014 | - | $191.40 M(+131.3%) |
| Dec 2013 | - | $82.73 M(+200.9%) |
| Sep 2013 | $27.50 M(+174.6%) | $27.50 M(-21.3%) |
| Jun 2013 | - | $34.96 M(+558.0%) |
| Mar 2013 | - | $5.31 M(-40.8%) |
| Dec 2012 | - | $8.97 M(-10.4%) |
| Sep 2012 | $10.01 M | $10.01 M(+6.9%) |
| Jun 2012 | - | $9.37 M(-23.5%) |
| Mar 2012 | - | $12.24 M(-24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $16.17 M(+26.4%) |
| Sep 2011 | $12.79 M(+41.4%) | $12.79 M(+20.4%) |
| Jun 2011 | - | $10.63 M(-12.1%) |
| Mar 2011 | - | $12.09 M(+50.1%) |
| Dec 2010 | - | $8.05 M(-11.0%) |
| Sep 2010 | $9.05 M(+86.2%) | $9.05 M(-10.6%) |
| Jun 2010 | - | $10.11 M(+72.1%) |
| Mar 2010 | - | $5.88 M(-11.9%) |
| Dec 2009 | - | $6.67 M(+37.3%) |
| Sep 2009 | $4.86 M(-60.5%) | $4.86 M(+30.8%) |
| Jun 2009 | - | $3.71 M(+814.6%) |
| Mar 2009 | - | $406.10 K(-91.9%) |
| Dec 2008 | - | $5.00 M(-59.4%) |
| Sep 2008 | $12.30 M(-53.2%) | $12.30 M(-6.1%) |
| Jun 2008 | - | $13.10 M(-31.3%) |
| Mar 2008 | - | $19.06 M(-19.8%) |
| Dec 2007 | - | $23.77 M(-9.6%) |
| Sep 2007 | $26.30 M(-14.2%) | $26.30 M(-20.7%) |
| Jun 2007 | - | $33.18 M(+35.5%) |
| Mar 2007 | - | $24.48 M(-18.8%) |
| Dec 2006 | - | $30.16 M(-1.7%) |
| Sep 2006 | $30.67 M(+17.4%) | $30.67 M(-18.5%) |
| Jun 2006 | - | $37.62 M(-8.7%) |
| Mar 2006 | - | $41.20 M(+76.6%) |
| Dec 2005 | - | $23.33 M(-10.7%) |
| Sep 2005 | $26.13 M(+176.5%) | $26.13 M(-8.2%) |
| Jun 2005 | - | $28.46 M(+128.7%) |
| Mar 2005 | - | $12.44 M(+51.3%) |
| Dec 2004 | - | $8.22 M(-13.0%) |
| Sep 2004 | $9.45 M(+565.5%) | $9.45 M(-12.9%) |
| Jun 2004 | - | $10.85 M(-5.4%) |
| Mar 2004 | - | $11.47 M(+444.3%) |
| Dec 2003 | - | $2.11 M(+48.4%) |
| Sep 2003 | $1.42 M(-191.6%) | $1.42 M(-180.9%) |
| Jun 2003 | - | -$1.75 M(+3.2%) |
| Mar 2003 | - | -$1.70 M(+6.6%) |
| Dec 2002 | - | -$1.60 M(+2.9%) |
| Sep 2002 | -$1.55 M(+18.9%) | -$1.55 M(+5.8%) |
| Jun 2002 | - | -$1.47 M(+6.4%) |
| Mar 2002 | - | -$1.38 M(+0.7%) |
| Dec 2001 | - | -$1.37 M(+4.8%) |
| Sep 2001 | -$1.30 M(+15.5%) | -$1.30 M(+4.9%) |
| Jun 2001 | - | -$1.24 M(+2.7%) |
| Mar 2001 | - | -$1.21 M(+4.4%) |
| Dec 2000 | - | -$1.16 M(+2.7%) |
| Sep 2000 | -$1.13 M(+13.4%) | -$1.13 M(-3.0%) |
| Jun 2000 | - | -$1.16 M(+5.2%) |
| Mar 2000 | - | -$1.11 M(+5.0%) |
| Dec 1999 | - | -$1.05 M |
| Sep 1999 | -$996.10 K(-64.4%) | - |
| Sep 1998 | -$2.80 M(+8.6%) | - |
| Sep 1997 | -$2.58 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual shareholders equity year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Arrowhead Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ARWR is $185.44 M
What is the all time high annual shareholders equity for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual stockholders equity is $461.78 M
What is Arrowhead Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ARWR annual stockholders equity has changed by -$85.90 M (-31.66%)
What is Arrowhead Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ARWR is $185.44 M
What is the all time high quarterly shareholders equity for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly stockholders equity is $500.08 M
What is Arrowhead Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ARWR quarterly stockholders equity has changed by -$298.35 M (-61.67%)